MedPacto (Korea) Today
| 235980 Stock | KRW 4,780 360.00 7.00% |
Performance0 of 100
| Odds Of DistressLess than 27
|
MedPacto is trading at 4780.00 as of the 13th of November 2024, a 7 percent decrease since the beginning of the trading day. The stock's open price was 5140.0. MedPacto has about a 27 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for MedPacto are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of November 2022 and ending today, the 13th of November 2024. Click here to learn more.
MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers MS-1601A that targets TRG1 for cancers and autoimmune diseases and vactosertib for solid tumors. More on MedPacto
Moving against MedPacto Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MedPacto Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MedPacto's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MedPacto or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology (View all Sectors) |
MedPacto (235980) is traded on KOSDAQ in Korea and employs 2 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 440.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedPacto's market, we take the total number of its shares issued and multiply it by MedPacto's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
MedPacto has accumulated about 1.29 B in cash with (25.15 B) of positive cash flow from operations.
Check MedPacto Probability Of Bankruptcy
Ownership AllocationThe market capitalization of MedPacto is W440.59 Billion. MedPacto holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check MedPacto Ownership Details
MedPacto Risk Profiles
Although MedPacto's alpha and beta are two of the key measurements used to evaluate MedPacto's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.12 | |||
| Standard Deviation | 3.0 | |||
| Variance | 9.02 | |||
| Risk Adjusted Performance | (0.17) |
MedPacto Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in MedPacto without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Other Information on Investing in MedPacto Stock
MedPacto financial ratios help investors to determine whether MedPacto Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedPacto with respect to the benefits of owning MedPacto security.